# Erector Spinae vs. PENG Block for Total Hip Arthroplasty

> **NCT06083428** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 90 (actual)

## Conditions studied

- Hip Arthropathy
- Hip Osteoarthritis
- Hip Pain Chronic

## Interventions

- **DRUG:** Ropivacaine 0.2% Injectable Solution Erector Spinae Plane Block
- **DRUG:** Ropivacaine 0.2% Injectable Solution - PENG block
- **DRUG:** Control Test

## Key facts

- **NCT ID:** NCT06083428
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-17
- **Primary completion:** 2024-06-11
- **Final completion:** 2024-06-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06083428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06083428, "Erector Spinae vs. PENG Block for Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06083428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*